Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06113211 · ClinicalTrials.gov registry record · Phase 4

Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures

A Phase 4 study of Opioid Use and Trauma, sponsored by Henry Ford Health System.

Recruiting
Registry status
Phase 4
Development phase
75
Enrollment target
1
Study location

NCT06113211: Recruiting Phase 4 study of Opioid Use and Trauma, sponsored by Henry Ford Health System.

NCT06113211 is a Phase 4 study of Opioid Use and Trauma that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 75 participants, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06113211, a Phase 4 study of Opioid Use and Trauma, is actively recruiting participants, sponsored by Henry Ford Health System.

RECRUITING
Registry status
Phase 4
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

An open reduction and internal fixation is a painful procedure requiring intensive postoperative pain management. Traditionally, opioid analgesia has been the gold standard for postoperative pain control. However, given the harmful side effect profile and opioid epidemic in the United States, it is advantageous to use alternate forms of analgesia. Multimodal pain control captures the effectiveness of different analgesic modalities and maximizes analgesia while minimizing side effects. The theory behind their use is that agents with different mechanisms of action work synergistically in preventing acute pain. Objective: To measure postoperative pain control in patients in two treatment arms of ORIF of the clavicle: a treatment group given a nonopioid pain control regimen, and a standard of care control group given standard opioid pain control regimen. Study Design: A randomized single blinded standard of care controlled clinical trial comparing pain management interventions. All adult patients scheduled for an ORIF following a traumatic fracture by fellowship trained Trauma surgeons will be eligible for inclusion. Patients will be excluded if their medical history presents known allergies or intolerance to Motrin, Lyrica, Tylenol, Zanaflex, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. On the day of surgery, patients will be randomized to receive a nonopioid pain control regimen or an opioid regimen using a computer-generated sequence. If pain is uncontrolled, patients will also be sent home with a prescription with 10 pills of 5 mg of Oxycodone for breakthrough pain. The amount of oxycodone taken will be recorded. Patients can call the resident on call, available 24-hours per day, if additional pain control is needed. Treatment: All patients will undergo previously scheduled ORIF of the clavicle in standard fashion and be randomized to the non-narcotic pain

Primary Outcome

Analog pain score 0-10. A pain score of 10 represents maximum pain and a pain score of 0 represents no pain.

Interventions

  • DRUG Narcotic pain medication
  • DRUG Nonnarcotic pain medications

Study Locations (1)

Michigan

  • Henry Ford Hospital System - Detroit

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-10-01
Est. Completion 2026-09-15
Phase Phase 4
Henry Ford Health System

234 total trials

What NCT06113211 shows while recruiting

NCT06113211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 148,259-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Opioid Use appearing as the primary indexed condition, and to 2 interventions - of which Narcotic pain medication is the first listed.

NCT06113211 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06113211 about?

NCT06113211 is a clinical study titled "Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures". An open reduction and internal fixation is a painful procedure requiring intensive postoperative pain management. Traditionally, opioid analgesia has been the gold standard for postoperative pain control. However, given the harmful side effect profile and opioid epidemic in the United States, it is ...

What is the current status of trial NCT06113211?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2024-10-01. Estimated completion is 2026-09-15.

What conditions does trial NCT06113211 study?

This clinical trial studies the following conditions: Opioid Use, Trauma, Fractures, Bone.

What interventions are being tested in trial NCT06113211?

The interventions under investigation include: Narcotic pain medication (DRUG), Nonnarcotic pain medications (DRUG).

Who is sponsoring clinical trial NCT06113211?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06113211 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06113211's enrollment target sits among peer trials

75 77th of 105 higher than 29 of 105 other Opioid Use trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06113211, the US trial registry maintained by the National Library of Medicine. NCT06113211 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.